Effects of Ayurvedic treatment on forty-three patients of ulcerative colitis
Total years in practice: 12
Ulcerative colitis is a chronic inflammatory bowel disease. Its incidence is more from 20 to 40 years of age and 5–10 per 100,000 persons are at risk. Bleeding in the stool with increased bowel frequency is the cardinal feature of this disease. Weakness is more common due to the loss of water and blood in the stool. In conventional Western medicine, some drugs like sulfasalazine may give mild relief in symptoms and signs but after some time patients need more doses of the same drug. Some patients get to benefit from steroids, which again are not suitable because of their side-effects. Even after taking steroids and sulfasalazine drugs patients suffer from the disease. So the patients are always seeking some alternative therapy promising more effective and safer outcomes.
The authors found some encouraging results in the patients of ulcerative colitis with certain Ayurvedic treatments. The treatment significantly corrected bleeding in stool and bowel frequency which are the cardinal features of ulcerative colitis, In addition, the treatments also improved the general condition of the patient. Ulcerative colitis is a disease of Purishavaha srotas. In Ayurveda, Raktatisara is mentioned as an advanced stage of Pittatisara. Piccha basti also mentioned as the management of Raktatisara in Charaka Samhita. This disease can be co-related with ulcerative colitis.
Aims and Objectives
The aims and objectives of this study were as follows –
To prove the efficacy of Ayurvedic treatment in the management of ulcerative colitis.
To provide a large population suffering from ulcerative colitis, a future possibility of safer treatment; this can be helpful in reducing the need of steroids and surgical processes.
Materials and Methods
Selection of patients
Forty-three cases with a classical picture of ulcerative colitis were randomly selected irrespective of age, sex, and chronicity from the OPD and IPD of the P. D. Patel Ayurveda Hospital, attached to J. S. Ayurveda College, Nadiad, Gujarat.
Criteria for inclusion
Signs and symptoms of ulcerative colitis
Colonoscopic diagnosis of ulcerative colitis
Criteria for exclusion
Patients who had undergone surgeries
Patients who had complications like anal fistula
Patients with any other associated disease
Plan of study and treatments
Proforma compiled with detailed clinical history and physical exam of the patients.
Investigations like Hb g%, Erythrocyte sedimentation rate, Stool routine - microscopy and colonoscopy
After confirming the diagnosis 43 patients were given the following treatment –
Udumbara kvatha (ingredient is Udumbar tvak-Ficus glomerata) – 40 ml/two times a day
Lodhra tvak churna (Symplocos racemosa) – 1 g + Musta moola churna (cyperus rotundus) – 1 g + Nagakesara (Mesua ferrea) churna – 1 g + Mukta panchamrut rasa-125 mg / three times in a day with water (the ingredients of Mukta panchamrut rasa are Mukta bhasma – 8 parts + Praval bhasma – 4 parts + Banga bhasma – 2 parts + Shankha bhasma - 1 part + Shukti bhasma – 1 part, processed in Ikshurasa, Godugdha, Vidai svarasa, Kumari svarasa, Shatavari Svarasa, Tulasi svarasa and Hansapadi svarasa).
Kutaja Ghana vati (ingredient is Kutaja tvak-Holarrhena antidysenterica) – 1g / three times a day.
Udumbara kvatha basti (ingredient is Udumbar tvak-Ficus glomerata) daily for one week and then twice a week for the next three weeks.
This treatment was given for a study period of one month.
Preparation of medicines
Medicines were prepared under expert supervision and purchased from Sunder Ayurveda Pharmacy, Nadiad.
Patients were kept on pitta –shamaka, laghu, grahi and pathya food articles.
If the patient was taking any modern medicine, doses of these were gradually reduced as the patient responded to Ayurvedic treatments.
Criteria for assessment
The improvement in the patients was assessed on the basis of relief in the symptoms and signs of the disease together with laboratory investigations. All the symptoms and signs were given grade scores and assessed before as well as after treatment. Changes in hemoglobin, ESR, and body weight were also recorded before and after treatment. Reductions in the doses of steroid and sulfasalazine drugs were also recorded.
Observations, Results and Discussion
Most of the patients (93.02%) belonged to the 20 – 40 years age group [Table 1]. In this study 65.12% of them were males and 34.88% were females [Table 2]. In other studies of modern medicines, the incidence of this disease in males and females is equal. Of the patients, 83.72% were Hindu [Table 3]; 46.51% had less than 1 year chronicity; 20.93% patients belonged to the 1 to 3 years chronicity group; 20.93% were found in the more than 3 to 5 years chronicity group. Only 11.63% patients were found in the more than 5 years’ chronicity group [Table 4].